ROCHE HOLDINGS AG SPN ADR EACH (RHHBY) Financials
RHHBY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 107.6 billion | 68.0 billion |
2023-06-30 | 93.8 billion | 60.1 billion |
2023-03-31 | ? | ? |
2022-12-31 | 95.3 billion | 65.1 billion |
RHHBY Free Cash Flow and Stock based compensation
No data available :(
RHHBY Net Income
Date | Net Income |
---|---|
2023-12-31 | 2.6 billion |
2023-06-30 | 4.0 billion |
2023-03-31 | 3.9 billion |
2022-12-31 | 2.1 billion |
RHHBY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 1.9 billion |
2023-06-30 | - | - | - |
2023-03-31 | - | - | - |
2022-12-31 | 10.6 billion | 23.1 billion | 1.3 billion |
RHHBY Shares Outstanding
RHHBY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-06-30 | 967.7 million | - | - | - |
2023-03-31 | 951.8 million | - | - | - |
2022-12-31 | 954.0 million | - | 7.0 billion | - |
RHHBY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | 33.5 billion | 9.7 billion |
RHHBY
Price: $29.83
Dividend Yield: 0.31%
Forward Dividend Yield: 4.67%
Payout Ratio: 70.00%
Dividend Per Share: 1.39 USD
Earnings Per Share: 1.99 USD
P/E Ratio: 16.02
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.5 million
Ebitda: 21.5 billionMarket Capitalization: 194.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 21
DGR3: 3.54%
DGR5: 3.79%
DGR10: 2.73%